According to @godbole17, Leap Therapeutics announced a $50 million purchase of Zcash (ZEC), with the post referencing on-chain researcher @ad1_onchain as the source; source: @godbole17 on X. Given the potentially market-moving nature of this claim, traders should treat it as unconfirmed until corroborated by official company communications or filings and monitor ZEC spot volumes, order-book depth, and derivatives funding for reaction while managing position size accordingly; source: @godbole17 on X.